Assessment of Segmentary Hypertrophy of Future Remnant Liver after Liver Venous Deprivation: A Single-Center Study
: Liver venous deprivation (LVD) is a recent radiological technique that has shown promising results on Future Remnant Liver (FRL) hypertrophy. The aim of this retrospective study is to compare the segmentary hypertrophy of the FRL after LVD and after portal vein embolization (PVE). : Patients under...
Gespeichert in:
| Veröffentlicht in: | Cancers 2024-05, Vol.16 (11), p.1982 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 11 |
| container_start_page | 1982 |
| container_title | Cancers |
| container_volume | 16 |
| creator | Al Taweel, Bader Cassese, Gianluca Khayat, Salah Chazal, Maurice Navarro, Francis Guiu, Boris Panaro, Fabrizio |
| description | : Liver venous deprivation (LVD) is a recent radiological technique that has shown promising results on Future Remnant Liver (FRL) hypertrophy. The aim of this retrospective study is to compare the segmentary hypertrophy of the FRL after LVD and after portal vein embolization (PVE).
: Patients undergoing PVE or LVD between April 2015 and April 2020 were included. The segmentary volumes (seg 4, seg2+3 and seg1) were assessed before and after the radiological procedure.
: Forty-four patients were included: 26 undergoing PVE, 10 LVD and 8 eLVD. Volume gain of both segment 1 and segments 2+3 was significantly higher after LVD and eLVD than after PVE (segment 1: 27.33 ± 35.37 after PVE vs. 38.73% ± 13.47 after LVD and 79.13% ± 41.23 after eLVD,
= 0.0080; segments 2+3: 40.73% ± 40.53 after PVE vs. 45.02% ± 21.53 after LVD and 85.49% ± 45.51 after eLVD,
= 0.0137), while this was not true for segment 4. FRL hypertrophy was confirmed to be higher after LVD and eLVD than after PVE (33.53% ± 21.22 vs. 68.63% ± 42.03 vs. 28.11% ± 28.33, respectively,
= 0.0280).
: LVD and eLVD may induce greater hypertrophy of segment 1 and segments 2+3 when compared to PVE. |
| doi_str_mv | 10.3390/cancers16111982 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11171007</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A797898727</galeid><sourcerecordid>A797898727</sourcerecordid><originalsourceid>FETCH-LOGICAL-c373t-4b98211f4954ed713decd3c04eb4964a0f13aaad901280e8d97c6a03af1f08873</originalsourceid><addsrcrecordid>eNptktFrFDEQxhdRbKl99k0WfPHl2mRn3SS-yHFaWzgQPPU15LKTa8pucia7B_ffO-tdS1tMIBmS33yZL0xRvOXsAkCxS2uCxZR5wzlXsnpRnFZMVLOmUfXLR_FJcZ7zHaMBwEUjXhcnIKUCzuC0SPOcMecew1BGV65wM4Um7cvr_RbTkOL2dj_dXI3DmLD8gX0wxC79DlNp3EDrIf6NIY65_ILb5Hdm8DF8KuflyodNh7MFiRKzGsZ2_6Z45UyX8fy4nxW_rr7-XFzPlt-_3Szmy5kFAcOsXpMnzl2tPtbYCg4t2hYsq3Fdq6Y2zHEwxrSK8UoylK0StjEMjOOOSSngrPh80N2O6x5bSyUk02kqryd_Ohqvn94Ef6s3cafpOwVnbFL4cFRI8c-IedC9zxa7zgQkrxqYYJKerzih75-hd3FMgfwR1QiQAP9KOlIb06H2wUV62E6iei6UkEqKaqIu_kPRbLH3NgZ0ns6fJFweEmyKOSd0DyY501Or6GetQhnvHv_NA3_fGPAXkRe7CQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3067383387</pqid></control><display><type>article</type><title>Assessment of Segmentary Hypertrophy of Future Remnant Liver after Liver Venous Deprivation: A Single-Center Study</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central Open Access</source><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>PubMed Central</source><creator>Al Taweel, Bader ; Cassese, Gianluca ; Khayat, Salah ; Chazal, Maurice ; Navarro, Francis ; Guiu, Boris ; Panaro, Fabrizio</creator><creatorcontrib>Al Taweel, Bader ; Cassese, Gianluca ; Khayat, Salah ; Chazal, Maurice ; Navarro, Francis ; Guiu, Boris ; Panaro, Fabrizio</creatorcontrib><description>: Liver venous deprivation (LVD) is a recent radiological technique that has shown promising results on Future Remnant Liver (FRL) hypertrophy. The aim of this retrospective study is to compare the segmentary hypertrophy of the FRL after LVD and after portal vein embolization (PVE).
: Patients undergoing PVE or LVD between April 2015 and April 2020 were included. The segmentary volumes (seg 4, seg2+3 and seg1) were assessed before and after the radiological procedure.
: Forty-four patients were included: 26 undergoing PVE, 10 LVD and 8 eLVD. Volume gain of both segment 1 and segments 2+3 was significantly higher after LVD and eLVD than after PVE (segment 1: 27.33 ± 35.37 after PVE vs. 38.73% ± 13.47 after LVD and 79.13% ± 41.23 after eLVD,
= 0.0080; segments 2+3: 40.73% ± 40.53 after PVE vs. 45.02% ± 21.53 after LVD and 85.49% ± 45.51 after eLVD,
= 0.0137), while this was not true for segment 4. FRL hypertrophy was confirmed to be higher after LVD and eLVD than after PVE (33.53% ± 21.22 vs. 68.63% ± 42.03 vs. 28.11% ± 28.33, respectively,
= 0.0280).
: LVD and eLVD may induce greater hypertrophy of segment 1 and segments 2+3 when compared to PVE.</description><identifier>ISSN: 2072-6694</identifier><identifier>EISSN: 2072-6694</identifier><identifier>DOI: 10.3390/cancers16111982</identifier><identifier>PMID: 38893103</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Care and treatment ; Chemotherapy ; Development and progression ; Embolization ; Hepatectomy ; Hepatic vein ; Hepatomegaly ; Hypertrophy ; Liver ; Liver cirrhosis ; Liver diseases ; Liver tumors ; Medical imaging ; Methods ; Mortality ; Patient outcomes ; Patients ; Portal vein ; Preoperative care ; Risk factors ; Safety and security measures ; Surgery ; Veins & arteries</subject><ispartof>Cancers, 2024-05, Vol.16 (11), p.1982</ispartof><rights>COPYRIGHT 2024 MDPI AG</rights><rights>2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2024 by the authors. 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11171007/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11171007/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,729,782,786,887,27931,27932,53798,53800</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38893103$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Al Taweel, Bader</creatorcontrib><creatorcontrib>Cassese, Gianluca</creatorcontrib><creatorcontrib>Khayat, Salah</creatorcontrib><creatorcontrib>Chazal, Maurice</creatorcontrib><creatorcontrib>Navarro, Francis</creatorcontrib><creatorcontrib>Guiu, Boris</creatorcontrib><creatorcontrib>Panaro, Fabrizio</creatorcontrib><title>Assessment of Segmentary Hypertrophy of Future Remnant Liver after Liver Venous Deprivation: A Single-Center Study</title><title>Cancers</title><addtitle>Cancers (Basel)</addtitle><description>: Liver venous deprivation (LVD) is a recent radiological technique that has shown promising results on Future Remnant Liver (FRL) hypertrophy. The aim of this retrospective study is to compare the segmentary hypertrophy of the FRL after LVD and after portal vein embolization (PVE).
: Patients undergoing PVE or LVD between April 2015 and April 2020 were included. The segmentary volumes (seg 4, seg2+3 and seg1) were assessed before and after the radiological procedure.
: Forty-four patients were included: 26 undergoing PVE, 10 LVD and 8 eLVD. Volume gain of both segment 1 and segments 2+3 was significantly higher after LVD and eLVD than after PVE (segment 1: 27.33 ± 35.37 after PVE vs. 38.73% ± 13.47 after LVD and 79.13% ± 41.23 after eLVD,
= 0.0080; segments 2+3: 40.73% ± 40.53 after PVE vs. 45.02% ± 21.53 after LVD and 85.49% ± 45.51 after eLVD,
= 0.0137), while this was not true for segment 4. FRL hypertrophy was confirmed to be higher after LVD and eLVD than after PVE (33.53% ± 21.22 vs. 68.63% ± 42.03 vs. 28.11% ± 28.33, respectively,
= 0.0280).
: LVD and eLVD may induce greater hypertrophy of segment 1 and segments 2+3 when compared to PVE.</description><subject>Care and treatment</subject><subject>Chemotherapy</subject><subject>Development and progression</subject><subject>Embolization</subject><subject>Hepatectomy</subject><subject>Hepatic vein</subject><subject>Hepatomegaly</subject><subject>Hypertrophy</subject><subject>Liver</subject><subject>Liver cirrhosis</subject><subject>Liver diseases</subject><subject>Liver tumors</subject><subject>Medical imaging</subject><subject>Methods</subject><subject>Mortality</subject><subject>Patient outcomes</subject><subject>Patients</subject><subject>Portal vein</subject><subject>Preoperative care</subject><subject>Risk factors</subject><subject>Safety and security measures</subject><subject>Surgery</subject><subject>Veins & arteries</subject><issn>2072-6694</issn><issn>2072-6694</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNptktFrFDEQxhdRbKl99k0WfPHl2mRn3SS-yHFaWzgQPPU15LKTa8pucia7B_ffO-tdS1tMIBmS33yZL0xRvOXsAkCxS2uCxZR5wzlXsnpRnFZMVLOmUfXLR_FJcZ7zHaMBwEUjXhcnIKUCzuC0SPOcMecew1BGV65wM4Um7cvr_RbTkOL2dj_dXI3DmLD8gX0wxC79DlNp3EDrIf6NIY65_ILb5Hdm8DF8KuflyodNh7MFiRKzGsZ2_6Z45UyX8fy4nxW_rr7-XFzPlt-_3Szmy5kFAcOsXpMnzl2tPtbYCg4t2hYsq3Fdq6Y2zHEwxrSK8UoylK0StjEMjOOOSSngrPh80N2O6x5bSyUk02kqryd_Ohqvn94Ef6s3cafpOwVnbFL4cFRI8c-IedC9zxa7zgQkrxqYYJKerzih75-hd3FMgfwR1QiQAP9KOlIb06H2wUV62E6iei6UkEqKaqIu_kPRbLH3NgZ0ns6fJFweEmyKOSd0DyY501Or6GetQhnvHv_NA3_fGPAXkRe7CQ</recordid><startdate>20240523</startdate><enddate>20240523</enddate><creator>Al Taweel, Bader</creator><creator>Cassese, Gianluca</creator><creator>Khayat, Salah</creator><creator>Chazal, Maurice</creator><creator>Navarro, Francis</creator><creator>Guiu, Boris</creator><creator>Panaro, Fabrizio</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7TO</scope><scope>7XB</scope><scope>8FE</scope><scope>8FH</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20240523</creationdate><title>Assessment of Segmentary Hypertrophy of Future Remnant Liver after Liver Venous Deprivation: A Single-Center Study</title><author>Al Taweel, Bader ; Cassese, Gianluca ; Khayat, Salah ; Chazal, Maurice ; Navarro, Francis ; Guiu, Boris ; Panaro, Fabrizio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c373t-4b98211f4954ed713decd3c04eb4964a0f13aaad901280e8d97c6a03af1f08873</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Care and treatment</topic><topic>Chemotherapy</topic><topic>Development and progression</topic><topic>Embolization</topic><topic>Hepatectomy</topic><topic>Hepatic vein</topic><topic>Hepatomegaly</topic><topic>Hypertrophy</topic><topic>Liver</topic><topic>Liver cirrhosis</topic><topic>Liver diseases</topic><topic>Liver tumors</topic><topic>Medical imaging</topic><topic>Methods</topic><topic>Mortality</topic><topic>Patient outcomes</topic><topic>Patients</topic><topic>Portal vein</topic><topic>Preoperative care</topic><topic>Risk factors</topic><topic>Safety and security measures</topic><topic>Surgery</topic><topic>Veins & arteries</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Al Taweel, Bader</creatorcontrib><creatorcontrib>Cassese, Gianluca</creatorcontrib><creatorcontrib>Khayat, Salah</creatorcontrib><creatorcontrib>Chazal, Maurice</creatorcontrib><creatorcontrib>Navarro, Francis</creatorcontrib><creatorcontrib>Guiu, Boris</creatorcontrib><creatorcontrib>Panaro, Fabrizio</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection (ProQuest)</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Research Library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancers</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Al Taweel, Bader</au><au>Cassese, Gianluca</au><au>Khayat, Salah</au><au>Chazal, Maurice</au><au>Navarro, Francis</au><au>Guiu, Boris</au><au>Panaro, Fabrizio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Assessment of Segmentary Hypertrophy of Future Remnant Liver after Liver Venous Deprivation: A Single-Center Study</atitle><jtitle>Cancers</jtitle><addtitle>Cancers (Basel)</addtitle><date>2024-05-23</date><risdate>2024</risdate><volume>16</volume><issue>11</issue><spage>1982</spage><pages>1982-</pages><issn>2072-6694</issn><eissn>2072-6694</eissn><abstract>: Liver venous deprivation (LVD) is a recent radiological technique that has shown promising results on Future Remnant Liver (FRL) hypertrophy. The aim of this retrospective study is to compare the segmentary hypertrophy of the FRL after LVD and after portal vein embolization (PVE).
: Patients undergoing PVE or LVD between April 2015 and April 2020 were included. The segmentary volumes (seg 4, seg2+3 and seg1) were assessed before and after the radiological procedure.
: Forty-four patients were included: 26 undergoing PVE, 10 LVD and 8 eLVD. Volume gain of both segment 1 and segments 2+3 was significantly higher after LVD and eLVD than after PVE (segment 1: 27.33 ± 35.37 after PVE vs. 38.73% ± 13.47 after LVD and 79.13% ± 41.23 after eLVD,
= 0.0080; segments 2+3: 40.73% ± 40.53 after PVE vs. 45.02% ± 21.53 after LVD and 85.49% ± 45.51 after eLVD,
= 0.0137), while this was not true for segment 4. FRL hypertrophy was confirmed to be higher after LVD and eLVD than after PVE (33.53% ± 21.22 vs. 68.63% ± 42.03 vs. 28.11% ± 28.33, respectively,
= 0.0280).
: LVD and eLVD may induce greater hypertrophy of segment 1 and segments 2+3 when compared to PVE.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>38893103</pmid><doi>10.3390/cancers16111982</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2072-6694 |
| ispartof | Cancers, 2024-05, Vol.16 (11), p.1982 |
| issn | 2072-6694 2072-6694 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11171007 |
| source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central Open Access; MDPI - Multidisciplinary Digital Publishing Institute; PubMed Central |
| subjects | Care and treatment Chemotherapy Development and progression Embolization Hepatectomy Hepatic vein Hepatomegaly Hypertrophy Liver Liver cirrhosis Liver diseases Liver tumors Medical imaging Methods Mortality Patient outcomes Patients Portal vein Preoperative care Risk factors Safety and security measures Surgery Veins & arteries |
| title | Assessment of Segmentary Hypertrophy of Future Remnant Liver after Liver Venous Deprivation: A Single-Center Study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-05T04%3A17%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Assessment%20of%20Segmentary%20Hypertrophy%20of%20Future%20Remnant%20Liver%20after%20Liver%20Venous%20Deprivation:%20A%20Single-Center%20Study&rft.jtitle=Cancers&rft.au=Al%20Taweel,%20Bader&rft.date=2024-05-23&rft.volume=16&rft.issue=11&rft.spage=1982&rft.pages=1982-&rft.issn=2072-6694&rft.eissn=2072-6694&rft_id=info:doi/10.3390/cancers16111982&rft_dat=%3Cgale_pubme%3EA797898727%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3067383387&rft_id=info:pmid/38893103&rft_galeid=A797898727&rfr_iscdi=true |